Goodwin Biotechnology, Inc.

GBI is a world-class CMO that excels as a strategic partner to deliver the highest quality material from proof of concept through Phase I / II clinical trials by employing superior cGMP compliant services that enable cost-effective, on-time delivery of our client's pre-clinical and clinical supplies to enhance patient's lives. 

While many CMOs entered the biotechnology CMO market as a for-profit organization, GBI has a different heritage. Born from the Goodwin Institute for Cancer Research, one of the first manifestations was the value of blending scientific expertise with a passion for the patient. This fueled a number of promising advancements in the treatment of cancer at the bench top level. The rigors of scaling up with therapeutics to test that promise, coupled with governmental rules and regulations, fueled an important business decision in 1992, Goodwin Biotechnology, Inc. was born. 

For more information:
PH: (954) 327-9639